situation of neurogenomics in Egypt, one of the biggest African countries. The authors underscore various challenges and also propose possible solutions. This is in accordance with the commentary by Karikari and Quansah who discuss the challenges and opportunities for neurogenomics in Ghana. Both commentaries emphasize that improved funding and policy support for neurogenomics research would be important to attract and equip the best-trained scientists in this area. Mohamed and colleagues study the NDUFA12L mitochondrial complex-I assembly factor, showing a nice example of neuroscience research carried out in Africa. These authors conclude that polymorphisms in NDUFA12L may play a crucial role in the development of neurodegenerative tauopathies, and suggest that NDUFA12L screening might be used to identify risk groups for such disorders. On the other hand, a research paper by Saxena and colleagues presents the Asian work in neuroscience. These authors demonstrate a role for antioxidant enzymes in chronic brain ischemia using a rat model with bilateral occlusion of the common carotid arteries. This link between oxidative stress and progressive neuronal damage in chronic ischemia may open up therapeutic strategies.
These and other advances in neurogenomics are the basis for novel medical applications, thus finding their way into the clinical arena. The report of a young patient with progressive spastic paraplegia diagnosed with SPG11, by Cristina Castro and colleagues, inaugurates a section in the journal dedicated to genomics case reports. The authors emphasize the importance of combining high-throughput sequencing technologies with skilled, thorough clinical evaluation in order to maximize the diagnostic efficacy of next generation sequencing. When it comes to diagnosing genetic neuropsychiatric disorders with genomic analyses, psychological and ethical questions that have to be handled appropriately arise. This is the focus of the paper by Ryan and coworkers, who review the context of genetic counseling in adolescent psychiatry. The authors provide insightful reflections on the main issues and address some elements of the genetic counseling protocol that may help maximize its benefits and minimize potential harm. In a broader sense, handling ethical, legal and social issues is a challenge for any genomic research on neuropsychiatric and neurodevelopmental disorders, since the traits investigated are related with the very essence of human individuality: cognition, personality and behavior. This is the focus of the paper by Canli and collaborators, who refer to neurogenethics as an emerging discipline at the intersection of ethics, neuroscience and genomics.
Finally, we would like to express our deep gratitude to the authors and reviewers of this Special Issue. We hope that you will find these articles instructive and thought provoking. We welcome your opinions
